Martha J. Demski's most recent trade in Alpha Teknova Inc was a trade of 8,000 Common Stock done at an average price of $5.1 . Disclosure was reported to the exchange on June 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alpha Teknova Inc | Martha J. Demski | Director | Sale of securities on an exchange or to another person at price $ 5.06 per share. | 27 Jun 2025 | 8,000 | 12,000 | - | 5.1 | 40,512 | Common Stock |
| Alpha Teknova Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 54,300 | 74,300 | - | 0 | Common Stock | |
| Alpha Teknova Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 54,300 | 54,300 | - | - | Non-Qualified Stock Option (right to buy) | |
| Equillium Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 20,000 | 20,000 | - | - | Director Stock Option (right to buy) | |
| Chimerix Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 8.55 per share. | 21 Apr 2025 | 72,055 | 0 (0%) | 0% | 8.5 | 616,070 | Common Stock |
| Chimerix Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 60,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 60,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 50,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 35,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 35,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 21,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 21,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 21,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 9,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 9,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Equillium Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 24,000 | 24,000 | - | - | Director Stock Option (right to buy) | |
| Equillium Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 24,000 | 0 | - | - | Director Stock Option (right to buy) | |
| Equillium Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 20,770 | 20,770 | - | - | Director Stock Option (right to buy) | |
| Equillium Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 20,770 | 0 | - | - | Director Stock Option (right to buy) | |
| Equillium Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 20,000 | 20,000 | - | - | Director Stock Option (right to buy) | |
| Equillium Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 20,000 | 0 | - | - | Director Stock Option (right to buy) | |
| Equillium Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 12,000 | 12,000 | - | - | Director Stock Option (right to buy) | |
| Equillium Inc | Martha J. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Feb 2025 | 12,000 | 0 | - | - | Director Stock Option (right to buy) | |
| Alpha Teknova Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 20,000 | 20,000 | - | 0 | Common Stock | |
| Chimerix Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Equillium Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Chimerix Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Equillium Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Chimerix Inc | Martha J. Demski | Director | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 10 May 2023 | 18,000 | 72,055 (0%) | 0% | 1.1 | 19,980 | Common Stock |
| Adma Biologics Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 51,630 | 51,630 | - | - | Employee Stock Option (right to buy) | |
| Adma Biologics Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 25,815 | 56,601 (0%) | 0% | 0 | Common Stock | |
| Chimerix Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Equillium Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Chimerix Inc | Martha J. Demski | Director | Purchase of securities on an exchange or from another person at price $ 1.61 per share. | 17 May 2022 | 10,000 | 54,055 (0%) | 0% | 1.6 | 16,100 | Common Stock |
| Adma Biologics Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 53,172 | 53,172 | - | - | Employee Stock Option (right to buy) | |
| Adma Biologics Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 26,586 | 30,786 (0%) | 0% | 0 | Common Stock | |
| Chimerix Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Equillium Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 20,770 | 20,770 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | Martha J. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Chimerix Inc | Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2020 | 7,042 | 0 | - | - | Stock Option (Right to Buy) | |
| Chimerix Inc | Martha J. Demski | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Nov 2020 | 7,042 | 44,055 (0%) | 0% | 0 | Common Stock | |
| Chimerix Inc | Martha J. Demski | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Nov 2020 | 7,042 | 0 (0%) | 0% | 0 | Common Stock | |
| Chimerix Inc | Martha J. Demski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.35 per share. | 17 Nov 2020 | 7,042 | 7,042 (0%) | 0% | 2.4 | 16,549 | Common Stock |
| Adma Biologics Inc | Martha J. Demski | Director | Purchase of securities on an exchange or from another person at price $ 2.29 per share. | 11 Sep 2020 | 2,200 | 4,200 (0%) | 0% | 2.3 | 5,038 | Common Stock |